Correlation Between Terns Pharmaceuticals and Merus BV
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Merus BV, you can compare the effects of market volatilities on Terns Pharmaceuticals and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Merus BV.
Diversification Opportunities for Terns Pharmaceuticals and Merus BV
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Terns and Merus is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Merus BV go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Merus BV
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 1.51 times less return on investment than Merus BV. In addition to that, Terns Pharmaceuticals is 1.47 times more volatile than Merus BV. It trades about 0.03 of its total potential returns per unit of risk. Merus BV is currently generating about 0.07 per unit of volatility. If you would invest 2,050 in Merus BV on July 20, 2024 and sell it today you would earn a total of 3,124 from holding Merus BV or generate 152.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Terns Pharmaceuticals vs. Merus BV
Performance |
Timeline |
Terns Pharmaceuticals |
Merus BV |
Terns Pharmaceuticals and Merus BV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Terns Pharmaceuticals and Merus BV
The main advantage of trading using opposite Terns Pharmaceuticals and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Valuation Check real value of public entities based on technical and fundamental data |